Product NDC: | 0378-3701 |
Proprietary Name: | Rizatriptan Benzoate |
Non Proprietary Name: | rizatriptan benzoate |
Active Ingredient(s): | 5 mg/1 & nbsp; rizatriptan benzoate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0378-3701 |
Labeler Name: | Mylan Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078173 |
Marketing Category: | ANDA |
Start Marketing Date: | 20121231 |
Package NDC: | 0378-3701-56 |
Package Description: | 6 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (0378-3701-56) |
NDC Code | 0378-3701-56 |
Proprietary Name | Rizatriptan Benzoate |
Package Description | 6 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (0378-3701-56) |
Product NDC | 0378-3701 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | rizatriptan benzoate |
Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
Route Name | ORAL |
Start Marketing Date | 20121231 |
Marketing Category Name | ANDA |
Labeler Name | Mylan Pharmaceuticals Inc. |
Substance Name | RIZATRIPTAN BENZOATE |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |